NCAPG2 and cancer: NCAPG2 was even more significantly linked to PFS in pan-cancer, with low PFS seen in LGG, LUAD, KIRP, PRAD, LUSC, LIHC, BLCA, MESO, UVM, PAAD, ACC and KICH (Figure S4).